vs

Side-by-side financial comparison of MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI) and Plymouth Industrial REIT, Inc. (PLYM). Click either name above to swap in a different company.

Plymouth Industrial REIT, Inc. is the larger business by last-quarter revenue ($51.2M vs $49.9M, roughly 1.0× MARAVAI LIFESCIENCES HOLDINGS, INC.). MARAVAI LIFESCIENCES HOLDINGS, INC. runs the higher net margin — -71.6% vs -106.3%, a 34.7% gap on every dollar of revenue. On growth, Plymouth Industrial REIT, Inc. posted the faster year-over-year revenue change (-1.4% vs -11.8%). Over the past eight quarters, Plymouth Industrial REIT, Inc.'s revenue compounded faster (0.4% CAGR vs -11.9%).

Maravai LifeSciences Holdings is a global life sciences firm developing critical reagents, diagnostic products, and tech solutions to support biopharma research, drug development, clinical diagnostics, and cell/gene therapy manufacturing. It serves biotech, pharma, research bodies and labs worldwide across three core segments.

Plymouth Industrial REIT, Inc. is a real estate investment trust focused on owning, operating, and acquiring high-quality industrial properties including distribution centers, warehouses, and light industrial facilities across key U.S. logistics hubs. It serves tenants in e-commerce, retail, manufacturing, and third-party logistics sectors, supporting diverse business supply chain needs.

MRVI vs PLYM — Head-to-Head

Bigger by revenue
PLYM
PLYM
1.0× larger
PLYM
$51.2M
$49.9M
MRVI
Growing faster (revenue YoY)
PLYM
PLYM
+10.5% gap
PLYM
-1.4%
-11.8%
MRVI
Higher net margin
MRVI
MRVI
34.7% more per $
MRVI
-71.6%
-106.3%
PLYM
Faster 2-yr revenue CAGR
PLYM
PLYM
Annualised
PLYM
0.4%
-11.9%
MRVI

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
MRVI
MRVI
PLYM
PLYM
Revenue
$49.9M
$51.2M
Net Profit
$-35.7M
$-54.4M
Gross Margin
25.8%
Operating Margin
-117.9%
-102.5%
Net Margin
-71.6%
-106.3%
Revenue YoY
-11.8%
-1.4%
Net Profit YoY
-37.7%
-248.5%
EPS (diluted)
$-0.24
$-1.23

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MRVI
MRVI
PLYM
PLYM
Q4 25
$49.9M
Q3 25
$41.6M
$51.2M
Q2 25
$47.4M
$47.2M
Q1 25
$46.9M
$45.6M
Q4 24
$56.6M
$47.6M
Q3 24
$69.0M
$51.9M
Q2 24
$69.4M
$48.7M
Q1 24
$64.2M
$50.2M
Net Profit
MRVI
MRVI
PLYM
PLYM
Q4 25
$-35.7M
Q3 25
$-25.6M
$-54.4M
Q2 25
$-39.6M
$-6.1M
Q1 25
$-29.9M
$5.8M
Q4 24
$-25.9M
$147.4M
Q3 24
$-97.1M
$-15.6M
Q2 24
$-9.8M
$1.3M
Q1 24
$-12.1M
$6.2M
Gross Margin
MRVI
MRVI
PLYM
PLYM
Q4 25
25.8%
Q3 25
13.6%
Q2 25
16.4%
Q1 25
16.5%
Q4 24
34.3%
Q3 24
46.7%
Q2 24
44.4%
Q1 24
40.3%
Operating Margin
MRVI
MRVI
PLYM
PLYM
Q4 25
-117.9%
Q3 25
-98.6%
-102.5%
Q2 25
-139.8%
-10.3%
Q1 25
-104.9%
Q4 24
-66.7%
Q3 24
-239.9%
-29.6%
Q2 24
-19.4%
2.7%
Q1 24
-29.4%
Net Margin
MRVI
MRVI
PLYM
PLYM
Q4 25
-71.6%
Q3 25
-61.4%
-106.3%
Q2 25
-83.5%
-12.9%
Q1 25
-63.9%
12.8%
Q4 24
-45.8%
309.9%
Q3 24
-140.6%
-30.1%
Q2 24
-14.1%
2.7%
Q1 24
-18.8%
12.4%
EPS (diluted)
MRVI
MRVI
PLYM
PLYM
Q4 25
$-0.24
Q3 25
$-0.18
$-1.23
Q2 25
$-0.27
$-0.14
Q1 25
$-0.21
$0.13
Q4 24
$-0.21
$3.24
Q3 24
$-0.68
$-0.35
Q2 24
$-0.07
$0.03
Q1 24
$-0.09
$0.14

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MRVI
MRVI
PLYM
PLYM
Cash + ST InvestmentsLiquidity on hand
$216.9M
Total DebtLower is stronger
$291.8M
Stockholders' EquityBook value
$212.4M
$470.1M
Total Assets
$770.6M
$1.6B
Debt / EquityLower = less leverage
1.37×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MRVI
MRVI
PLYM
PLYM
Q4 25
$216.9M
Q3 25
$243.6M
Q2 25
$269.9M
Q1 25
$285.1M
Q4 24
$322.4M
Q3 24
$578.2M
Q2 24
$573.2M
Q1 24
$561.7M
Total Debt
MRVI
MRVI
PLYM
PLYM
Q4 25
$291.8M
Q3 25
$292.8M
Q2 25
$293.9M
Q1 25
$294.9M
Q4 24
$295.9M
$646.4M
Q3 24
$521.7M
Q2 24
$522.5M
Q1 24
$523.3M
Stockholders' Equity
MRVI
MRVI
PLYM
PLYM
Q4 25
$212.4M
Q3 25
$245.4M
$470.1M
Q2 25
$265.9M
$539.6M
Q1 25
$300.6M
$571.0M
Q4 24
$325.3M
$579.5M
Q3 24
$344.9M
$436.5M
Q2 24
$434.7M
$475.2M
Q1 24
$410.7M
$484.6M
Total Assets
MRVI
MRVI
PLYM
PLYM
Q4 25
$770.6M
Q3 25
$849.2M
$1.6B
Q2 25
$897.0M
$1.6B
Q1 25
$959.8M
$1.4B
Q4 24
$1.0B
$1.4B
Q3 24
$1.3B
$1.5B
Q2 24
$1.4B
$1.4B
Q1 24
$1.4B
$1.4B
Debt / Equity
MRVI
MRVI
PLYM
PLYM
Q4 25
1.37×
Q3 25
1.19×
Q2 25
1.11×
Q1 25
0.98×
Q4 24
0.91×
1.12×
Q3 24
1.51×
Q2 24
1.20×
Q1 24
1.27×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MRVI
MRVI
PLYM
PLYM
Operating Cash FlowLast quarter
$-22.8M
$20.0M
Free Cash FlowOCF − Capex
$-24.9M
FCF MarginFCF / Revenue
-49.9%
Capex IntensityCapex / Revenue
4.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-70.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MRVI
MRVI
PLYM
PLYM
Q4 25
$-22.8M
Q3 25
$-15.2M
$20.0M
Q2 25
$-10.3M
$23.4M
Q1 25
$-9.4M
$15.6M
Q4 24
$-14.6M
$96.1M
Q3 24
$13.1M
$17.6M
Q2 24
$17.4M
$19.9M
Q1 24
$-8.5M
$16.6M
Free Cash Flow
MRVI
MRVI
PLYM
PLYM
Q4 25
$-24.9M
Q3 25
$-18.1M
Q2 25
$-13.1M
Q1 25
$-14.6M
Q4 24
$-20.5M
Q3 24
$4.5M
Q2 24
$7.9M
Q1 24
$-14.1M
FCF Margin
MRVI
MRVI
PLYM
PLYM
Q4 25
-49.9%
Q3 25
-43.4%
Q2 25
-27.7%
Q1 25
-31.2%
Q4 24
-36.2%
Q3 24
6.6%
Q2 24
11.4%
Q1 24
-22.0%
Capex Intensity
MRVI
MRVI
PLYM
PLYM
Q4 25
4.2%
Q3 25
7.0%
Q2 25
6.1%
Q1 25
11.2%
Q4 24
10.3%
Q3 24
12.4%
Q2 24
13.8%
Q1 24
8.8%
Cash Conversion
MRVI
MRVI
PLYM
PLYM
Q4 25
Q3 25
Q2 25
Q1 25
2.67×
Q4 24
0.65×
Q3 24
Q2 24
15.12×
Q1 24
2.67×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MRVI
MRVI

Cygnus Segment$27.2M54%
Other$18.4M37%
Shipping And Handling$4.3M9%

PLYM
PLYM

Segment breakdown not available.

Related Comparisons